Interestingly, the body weight of mice treated with Ang/TAT‐sEVs‐Dox did not decrease until the day 21, however, the Blank‐sEVs‐Dox group showed a decreasing trend of the same.
← all excerpts
Specific anti-glioma targeted-delivery strategy of engineered small extracellular vesicles dual-functionalised by Angiopep-2 and TAT peptides.
1
—
—